Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure

Read more ››
By: PR Newswire Association LLC. - 04 May 2024
Related companies:  Pfizer Australia

Melospeech Inc. Achieves BBB4Good Verification, Highlighting Its Role as a Tech-Driven, Community-Focused Leader

Read more ››
By: PR Newswire Association LLC. - 04 May 2024

Second Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions.

Read more ››
By: PR Newswire Association LLC. - 04 May 2024

United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024

Read more ››
By: PR Newswire Association LLC. - 04 May 2024

Chemistree Directors Ratify Debenture Restructuring

Read more ››
By: PR Newswire Association LLC. - 04 May 2024

BetterLife Announces Intent to Complete Private Placement of Units

Read more ››
By: GlobeNewswire - 04 May 2024
Related companies:  BetterLife Pharma Inc.

National Institutes of Health All of Us Research Program Mobile Tour Visits Rochester, NY

Read more ››
By: PR Newswire Association LLC. - 04 May 2024

Butterfly Medical Welcomes Experienced Urology Executive to its Helm

Read more ››
By: PR Newswire Association LLC. - 04 May 2024
Related companies:  Butterfly Network, Inc

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS

Read more ››
By: PR Newswire Association LLC. - 04 May 2024
Related companies:  Filament Health Corp.

BioVaxys Technology Corp. Closes First Tranche of Private Placement

Read more ››
By: PR Newswire Association LLC. - 04 May 2024
Related companies:  BioVaxys Technology Corporation

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Arcutis Biotherapeutics, Inc.

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Vor BioPharma, Inc.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  NewAmsterdam Pharma B.V.

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Anika Therapeutics, Inc.

Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Aileron Therapeutics, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Taysha Gene Therapies, Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Terns Pharmaceuticals Inc.

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  electroCore, Inc.

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to June 3, 2024

Read more ››
By: GlobeNewswire - 03 May 2024

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

Read more ››
By: GlobeNewswire - 03 May 2024
Related companies:  Fate Therapeutics, Inc.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »